Global Health

Primary tabs

Mon, 2009-03-09 11:54 — mdmcdonald

The mission of the Global Health Working Group is to explore and improve current and emerging states of health and human security worldwide.

General Topic Tags:

Adaptation

Problem, Solution, SitRep, or ?:

Solutions

Group:

Request group membership

Group description:

This Working Group is focused on exploring current and emerging states of health and human security worldwide.

Group roles and permissions:

Use default roles and permissions

Group visibility:

Public - accessible to all site users

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Aboubacar Conte	admin	Albert Gomez	Allan	Anthony	Carrielaj
Chisina Kapungu	ChrisAllen	Corey Watts	CPetry	DeannaPolk	Elhadj Drame
Gavin Macgregor...	Hadiatou Balde	hank_test	jranck	JSole	Kathy Gilbeaux
Lisa Stelly Thomas	loguest	Maeryn Obley	mdmcdonald	MDMcDonald_me_com	Mika Shimizu
mike kraft	njchapman	Norea	Tiaji Salaam-Blyther	tnovotny

Request group membership

Email address for group

New statement: AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results

Wed, 2021-03-24 22:07 — mike kraft

After results are questioned, AstraZeneca says complete data shows its vaccine is still highly effective.

https://www.nytimes.com/live/2021/03/24/world/covid-vaccine-coronavirus-cases#after-results-are-questioned-astrazeneca-says-complete-data-shows-its-vaccine-is-still-highly-effective

AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday.

The company said in a news release that its vaccine was 76 percent effective at preventing Covid-19. That is slightly lower than the efficacy number that the company announced earlier this week.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New statement: AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results
Log in or register to post comments

WHO: How COVID-19 pandemic has affected TB detection and mortality

Wed, 2021-03-24 20:07 — mike kraft

Impact of the COVID-19 pandemic on TB detection and mortality in 2020

Provisional data compiled by the World Health Organization (WHO) from 84 countries indicates that an estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in 2019 - a reduction of 21% from 2019.

In the group of 10 high-burden countries with the largest reported shortfalls compared with 2019, the overall shortfall was 28%. With many people with TB unable to access care, WHO estimates that half a million more people may have died from TB in 2020 alone. TB remains one of the world’s top infectious killers.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO: How COVID-19 pandemic has affected TB detection and mortality
Log in or register to post comments

Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says

Wed, 2021-03-24 19:36 — mike kraft

Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says Reports of extremely rare blood clots should not deter governments from distributing the AstraZeneca vaccine to their citizens, according to the World Health Organization’s Chief Scientists Soumya Swaminathan. By <a href="/profiles/julia-hollingsworth">Julia Hollingsworth</a>, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Benefits of AstraZeneca vaccine outweigh any rare reactions, WHO chief scientist says
Log in or register to post comments

U.N. Human Rights Council calls for fair, affordable access to COVID-19 vaccines

Wed, 2021-03-24 19:26 — mike kraft

Top U.N. rights body calls for fair, affordable access to COVID-19 vaccines The United Nations Human Rights Council adopted a resolution on Tuesday calling for equitable, affordable access to COVID-19 vaccines and fair pricing. Stephanie Nebehay U.S.

GENEVA (Reuters) - The United Nations Human Rights Council adopted a resolution on Tuesday calling for equitable, affordable access to COVID-19 vaccines and fair pricing.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.N. Human Rights Council calls for fair, affordable access to COVID-19 vaccines
Log in or register to post comments

Calls for efforts and strategies to curb Covid-19 disinformation

Wed, 2021-03-24 19:00 — mike kraft

Facebook, Twitter must do more to stop COVID-19 anti-vaxxers, U.S. states say Attorneys general for 12 U.S. states on Wednesday accused Facebook Inc and Twitter Inc of doing too little to stop people from using their platforms to spread false information that coronavirus vaccines are unsafe. Jonathan Stempel U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Calls for efforts and strategies to curb Covid-19 disinformation
Log in or register to post comments

Germany: Angela Merkel backtracks on Easter lockdown after uproar

Wed, 2021-03-24 13:44 — mike kraft

Merkel backtracks on Easter lockdown after uproar In a turnabout move, German Chancellor Angela Merkel told state premiers in a video call that there would not be a strict lockdown over Easter after all. This follows a day of criticism and confusion in Germany. Deutsche Welle (www.dw.com) DW.COM

erman Chancellor Angela Merkel and the leaders of Germany's 16 states will reverse their plan to toughen virus lockdown measures over Easter.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Germany: Angela Merkel backtracks on Easter lockdown after uproar
Log in or register to post comments

New studies on COVID-19 Survivors' lingering effects, including greater impact on women

Wed, 2021-03-24 13:03 — mike kraft

Women in 40s, 50s who survive COVID more likely to suffer persistent problems: UK studies Women in their 40s and 50s appear more at risk of long-term problems following discharge from hospital after COVID-19, with many suffering months of persistent symptoms such as fatigue, breathlessness and brain fog, two UK studies found on Wednesday. Kate Kelland U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about New studies on COVID-19 Survivors' lingering effects, including greater impact on women
Log in or register to post comments

E.U. planning to Curb Covid Vaccine Exports for 6 Weeks

Tue, 2021-03-23 21:58 — mike kraft

BRUSSELS — The European Union is finalizing emergency legislation that will give it broad powers to curb exports for the next six weeks of Covid-19 vaccines manufactured in the bloc, a sharp escalation in its response to supply shortages at home that have created a political maelstrom amid a rising third wave on the continent.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about E.U. planning to Curb Covid Vaccine Exports for 6 Weeks
Log in or register to post comments

U.S. health officials and an oversight board accused AstraZeneca of presenting potentially misleading information

Tue, 2021-03-23 15:57 — mike kraft

Federal health officials and an independent oversight board accused AstraZeneca of presenting the world with potentially misleading information about the effectiveness of the company’s Covid-19 vaccine, an extraordinary blow to the credibility of a company whose product has been seen as critical to the global fight against the pandemic.

In a two-page letter to AstraZeneca and federal authorities on Monday, an independent panel of medical experts that was helping oversee the vaccine’s clinical trial in the United States said the company had essentially cherry-picked data that was “most favorable for the study as opposed to the most recent and most complete.”

Country / Region Tags:

General Topic Tags: